相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Standard Versus Cyclic Teriparatide and Denosumab Treatment for Osteoporosis: A Randomized Trial
Felicia Cosman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Comparative Physicochemical and Biological Characterisation of the Similar Biological Medicinal Product Teriparatide and Its Reference Medicinal Product
Piroska Kovacs et al.
BIODRUGS (2020)
A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration
Y. Ohbayashi et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Icariin prevents oestrogen deficiency-induced alveolar bone loss through promoting osteogenesis via STAT3
Hongyuan Xu et al.
CELL PROLIFERATION (2020)
Clinico-radiographic evaluation of 1% alendronate gel as an adjunct and smart blood derivative platelet rich fibrin in grade II furcation defects
Ishita Wanikar et al.
JOURNAL OF PERIODONTOLOGY (2019)
Evaluation of the effect of teriparatide therapy on mandibular fracture healing in rats with medication-related osteonecrosis of the jaw
Mohammad Zandi et al.
CLINICAL ORAL INVESTIGATIONS (2019)
Histatin-1 counteracts the cytotoxic and antimigratory effects of zoledronic acid in endothelial and osteoblast-like cells
Martin Castro et al.
JOURNAL OF PERIODONTOLOGY (2019)
Zoledronate treatment duration is linked to bisphosphonate-related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis
Jonathan G. Messer et al.
ORAL DISEASES (2019)
The antifibrotic and anti-inflammatory effects of icariin on the kidney in a unilateral ureteral obstruction mouse model
Hsin-An Chen et al.
PHYTOMEDICINE (2019)
Angiogenic and MMPs modulatory effects of icariin improved cutaneous wound healing in rats
Wangkheirakpam Ramdas Singh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Icariin promotes angiogenesis in glucocorticoid-induced osteonecrosis of femoral heads: In vitro and in vivo studies
Huachen Yu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Absorption and utilisation of epimedin C and icariin from Epimedii herba, and the regulatory mechanism via the BMP2/ Runx2 signalling pathway
Xiaowen Huang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Effects of zoledronic acid and dexamethasone on early phases of socket healing after tooth extraction in rats: A preliminary macroscopic and microscopic quantitative study
Giovanni Mergoni et al.
MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL (2019)
The effects of icariin on wound healing of extraction sites with administration of zoledronic and dexamethasone: A rat model study
Jie Liu et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2018)
Icariin: a Potential Compound for the Recovery of Tibial Dyschondroplasia Affected Chicken Via Up-Regulating BMP-2 Expression
Mujahid Iqbal et al.
BIOLOGICAL PROCEDURES ONLINE (2018)
Abaloparatide Exerts Bone Anabolic Effects with Less Stimulation of Bone Resorption-Related Factors: A Comparison with Teriparatide
Akito Makino et al.
CALCIFIED TISSUE INTERNATIONAL (2018)
Bisphosphonate Modulation of the Gene Expression of Different Markers Involved in Osteoblast Physiology: Possible Implications in Bisphosphonate-Related Osteonecrosis of the Jaw
Francisco Javier Manzano-Moreno et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2018)
Effect of different doses and durations of teriparatide therapy on resolution of medication-related osteonecrosis of the jaw: A randomized, controlled preclinical study in rats
Mohammad Zandi et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2018)
Icariin abrogates osteoclast formation through the regulation of the RANKL-mediated TRAF6/NF-kappa B/ERK signaling pathway in Raw264.7 cells
Buyun Kim et al.
PHYTOMEDICINE (2018)
RANKL and RANK: From Mammalian Physiology to Cancer Treatment
Shuan Rao et al.
TRENDS IN CELL BIOLOGY (2018)
IL-6 potentiates BMP-2-induced osteogenesis and adipogenesis via two different BMPR1A-mediated pathways
Ru-Lin Huang et al.
CELL DEATH & DISEASE (2018)
Bisphosphonates hinder osteoblastic/osteoclastic differentiation in the maxillary sinus mucosa-derived stem cells
Jun Zhang et al.
CLINICAL ORAL INVESTIGATIONS (2018)
Teriparatide Treatment Improves Bone Defect Healing Via Anabolic Effects on New Bone Formation and Non-Anabolic Effects on Inhibition of Mast Cells in a Murine Cranial Window Model
Longze Zhang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Long-term therapy with intravenous zoledronate increases the number of nonattached osteoclasts
Maria Jose H. Nagata et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2017)
Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro
Xin Huang et al.
MOLECULAR MEDICINE REPORTS (2016)
Controlled co-immobilization of EGF and VEGF to optimize vascular cell survival
Pauline Lequoy et al.
ACTA BIOMATERIALIA (2016)
Histopathological Effects of Teriparatide in Medication-Related Osteonecrosis of the Jaw: An Animal Study
Aydin Keskinruzgar et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2016)
Role of periodontal disease in bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats
Chun Lei Li et al.
CLINICAL ORAL IMPLANTS RESEARCH (2016)
Icariin Promotes Tendon-Bone Healing during Repair of Rotator Cuff Tears: A Biomechanical and Histological Study
Chenyi Ye et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Chemical Constituents, Quality Control, and Bioactivity of Epimedii Folium (Yinyanghuo)
Xiao-Jia Chen et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2015)
Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings
H. Kakehashi et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2015)
Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review
R. Fliefel et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2015)
Pharmacological effects and pharmacokinetic properties of icariin, the major bioactive component in Herba Epimedii
Chenrui Li et al.
LIFE SCIENCES (2015)
Biologic Agents for Periodontal Regeneration and Implant Site Development
Fernando Suarez-Lopez del Amo et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
Aliya A. Khan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw-2014 Update
Salvatore L. Ruggiero et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2014)
Bisphosphonates inhibit bone remodeling in the jaw bones of rats and delay healing following tooth extractions
Zaher Jabbour et al.
ORAL ONCOLOGY (2014)
A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ)
Katia Rupel et al.
ORAL ONCOLOGY (2014)
The Effect of Vacuum-Assisted Closure on the Bacterial Load and Type of Bacteria: A Systematic Review
Aryan S. P. Patmo et al.
ADVANCES IN WOUND CARE (2014)
Nitrogen-containing bisphosphonates inhibit RANKL- and M-CSF-induced osteoclast formation through the inhibition of ERK1/2 and Akt activation
Masanobu Tsubaki et al.
JOURNAL OF BIOMEDICAL SCIENCE (2014)
Bacteria-reactive Immune Response May Induce RANKL-expressing T Cells in the Mouse Periapical Bone Loss Lesion
Marcelo J. B. Silva et al.
JOURNAL OF ENDODONTICS (2012)
Molecular networks for the study of TCM Pharmacology
Jing Zhao et al.
BRIEFINGS IN BIOINFORMATICS (2010)
Teriparatide Therapy for Alendronate-Associated Osteonecrosis of the Jaw
Ada Cheung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Giant osteoclasts after long-term bisphosphonate therapy: diagnostic challenges
Nidhi Jain et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Giant Osteoclast Formation and Long-Term Oral Bisphosphonate Therapy
Robert S. Weinstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Icariin stimulates angiogenesis by activating the MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells
Byung-Hee Chung et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Acute changes in serum osteoprotegerin and receptor activator for nuclear factor-κB ligand levels in women with established osteoporosis treated with teriparatide
Athanasios D. Anastasilakis et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)